Scotiabank analyst Jason Bouvier downgrades Enerplus (TSX:ERF) from Sector Outperform to Sector Perform.
Wells Fargo Maintains Equal-Weight on CVS Health, Lowers Price Target to $101
Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Equal-Weight and lowers the price target from $106 to $101.